News from the healthcare data industry
November 07, 2022 02:31 PM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, an AI-driven health technology company and portfolio company of nference, announced today it has acquired NeuTrace, a medical technology company...
The Business Journal spoke with Myerson about his approach to building the health care data company and its latest innovations. Source: https://www.bizjournals.com/seattle/news/2022/11/04/truveta-ceo-terry-myerson-interview.html
November 04, 2022 09:30 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health is pleased to announce their attendance and presence at the ISPOR, The Professional Society for Health Economics and Outcomes...
In collaboration with iRhythm, Tempus is studying its predictive, AI-enabled algorithmic tests via a network of researchers to determine the impact of detecting patients at increased risk of developing cardiovascular...
There needs to be a bigger emphasis and move towards connecting the life science companies who are doing the work of using biomarkers to develop therapies with the health systems...
Fast and accurate generative AI design of novel antibodies extends Exscientia’s capabilities beyond small molecules Sequencing paired human antibody data to create better AI models for antibody design Automated laboratory...
November 03, 2022 06:00 ET | Source: Centogene NV CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 03, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for...
With proven results including cost savings and improved patient outcomes in more than 20 leading health systems, Carta Healthcare will use the funds to scale its business November 02, 2022...
Dr. Durga Borkar to Deliver Podium Talk at The Retina Society’s Annual Meeting SAN FRANCISCO, Nov. 2, 2022 /PRNewswire/ — During The Retina Society’s 55th Annual Scientific Meeting Nov. 2 to 5, Verana Health®—a digital...
RWD can deepen our understanding of patient journeys, reveal important treatment pathways, and demonstrate drug safety and efficacy under complex circumstances. But how much do you know about the standards...